Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)
Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)
The purpose of this clinical study is to find out if NNC0487-0111 is safe and effective for treating people who have excess body weight. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111 (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.
Key Inclusion Criteria:
Key Exclusion Criteria:
clinicaltrials@novonordisk.com(+1) 866-867-7178
Buenos Aires, C1425AGC, Argentina
Esperanza, Santa Fe, S3080BQV, Argentina
Paris, 75015, France
Pierre-Bénite, 69310, France
Saint-Herblain, 44800, France
Toulouse, 31059, France
Vénissieux, 69200, France
Cheshire, CH65 4LE, United Kingdom